Rexasertib News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rexasertib . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rexasertib Today - Breaking & Trending Today

FDA Grants Fast Track Designation to ACR-368 in Platinum-resistant Ovarian Cancer and Endometrial Cancer

Published: May 9, 2023

The FDA has granted fast track designations to ACR-368 monotherapy for the treatment of patients with platinum-resistant ovarian cancer and endometrial cancer who are positive for predicted sensitivity to the agent using Acrivon Therapeutics’ OncoSignature® test.

Source: onclive.com

Related Topics:

Acrivon OncosignaturePeter Blume JensenInternational Federation Of GynecologyAcrivon Therapeutic OncosignatureFast TrackCheckpoint KinaseFast Track DesignationAcr 368Platinum Resistant Ovarian CancerRexasertib Endometrial Cancer